Abstract
Data from in vivo studies have indicated a role
for Β-blockers in the prevention of bone loss. Some
epidemiological studies have found protective effects of
b-blockers on fracture risk. However, there is limited
information on the association with cumulative dose
and type of Β-blockers used. We conducted two casecontrol
studies using data from the UK General
... read more